Not Signed In -
Naloxone Injection |
Narcan |
Clinical Trial: Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
This study is currently recruiting patients.
Purpose
The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Opioid-Related Disorders | Drug: Buprenorphine | Phase III |
MedlinePlus related topics: Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules
Further Study Details:
Expected Total Enrollment: 509
Study start: January 2001
Eligibility
Ages Eligible for Study: 15 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Females are not pregnant or lactating
- Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment
Location and Contact Information
Jessica Fradis (310)312-0500 jfradis@friendsresearch.org
Colorado
Addiction Research & Treatment Services (ARTS), Denver, Colorado, 80204, United States; No longer recruiting
Denver Health & Hospitals Authority, Denver, Colorado, 80204, United States; No longer recruiting
Connecticut
Connecticut Counseling Centers, Waterbury, Connecticut, 06705, United States; Recruiting
Patricia Davis 203-755-8874
Hartford Dispensary, Hartford, Connecticut, 06120, United States; Recruiting
Mark Relyea 860-525-9376
New York
New York VA Medical Center, New York, New York, 10010, United States; Recruiting
Terry Leon 860-525-9376
LI Jewish Health System, Glen Oaks, New York, 11004, United States; Recruiting
Jessica Fradis 310-312-0500 jfradis@friendsresearch.org
North Carolina
Coastal Horizons Center, Inc., Wilmington, North Carolina, 28412, United States; Recruiting
Michael Yonkins 910-343-0145 Ext. 1065
South Light-Wakeview Clinic, Raleigh, North Carolina, 27610, United States; Recruiting
Denise Mcrae 919-832-4453 Ext. 212
Oregon
CODA, Portland, Oregon, 97214, United States; Recruiting
Sandy Kennard 503-239-8400
Virginia
Norfolk CSB, Norfolk, Virginia, 23505, United States; Recruiting
George Tucker 757-664-6683
Washington
Providence Behavioral Health Services, Everett, Washington, 98201, United States; No longer recruiting
Study chairs or principal investigators
Walter Ling, M.D., Principal Investigator, University of California, Los Angeles
More Information
Study ID Numbers: NIDA-CTN-0003-1
Record last reviewed: January 2005
Last Updated: April 7, 2005
Record first received: February 19, 2004
ClinicalTrials.gov Identifier: NCT00078117
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: January 2005
Last Updated: April 7, 2005
Record first received: February 19, 2004
ClinicalTrials.gov Identifier: NCT00078117
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
